drugset / Trial / NCT02754518

Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface Analysis

NCT02754518

Phase 4 Completed 40 enrolled University of Chicago
NaSingle-groupOpen-labelTreatment

Summary

This study intends to measure the effects of valsartan/sacubitril compared to baseline standard medical heart failure therapy on reverse remodeling using echocardiographic endocardial surface analysis techniques to assess changes in ventricular volume, function, and shape.

Timeline

Start
2016-04
Primary completion
2019-04
Completion
2019-04

Drugs

EvaluationDrugModalityDoseRoute
Subject LCZ696 Unknown

Indications